Alzheimer ’s disease (AD) has a long preclinical phase in which pathology develops years or decades before clinical symptoms. In study in JAMA Psychiatry, Robert Pietrzak, PhD, MPH and colleagues report that depression, anxiety and cognitive decline are associated with presence of Amyloidβ but that patients will benefit if their depression and anxiety are treated.
Finding brain beta amyloid is usefull in assessing Alzheimer's Disease. In a report in JAMA Neurology, Craig Curtis, MD, and colleagues report on a multicenter PET imaging study on terminally ill dementia patients using flutemetamol injections tagged with radioactive fluorine 18. In cases where autopsy was later possible, the team assessed how accurate the tests had been in diagnosing Alzheimer's.
Four factors have been identified that affect quality of life from the perspective of people with dementia. The findings were published in the January issue of the Journal of the American Geriatrics Society.
MRI scans are a viable testing option for early indicators of Alzheimer’s disease, according to research from Northwestern University.
Regularly speaking 2 or more languages can delay the onset and diagnosis of Alzheimer’s disease by 4 years, according to research from Belgium.
For nursing home residents with dementia taking statins, most continue statins with the progression to advanced dementia, according to research published in the November issue of the Journal of the American Geriatrics Society.